Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registry.

@article{Helm2010HyperthermicIC,
  title={Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registry.},
  author={Cyril William Helm and Scott D. Richard and Jianmin Pan and David Bartlett and Martin David Goodman and Rick Hoefer and Sam S Lentz and E. A. Levine and Brian W. Loggie and Daniel S. Metzinger and Brigitte E. Miller and Lynn P Parker and James E. Spellman and Paul H Sugarbaker and Robert Edwards and Shesh N. Rai},
  journal={International journal of gynecological cancer : official journal of the International Gynecological Cancer Society},
  year={2010},
  volume={20 1},
  pages={61-9}
}
INTRODUCTION An analysis of experience of surgical and gynecologic oncologists in the United States with the use of hyperthermic intraperitoneal chemotherapy for women with invasive epithelial ovarian cancer (EOC). METHODS An Internet-based registry (HYPER-O) collected data from collaborating institutions. Eligibility included women with EOC treated with hyperthermic intraperitoneal chemotherapy. Borderline and nonepithelial cancers were excluded. RESULTS As of July 1, 2008, 141 women were… CONTINUE READING